Adeno-Associated Virus-Mediated MicroRNA Delivery and Therapeutics
- 29 January 2015
- journal article
- review article
- Published by Georg Thieme Verlag KG in Seminars in Liver Disease
- Vol. 35 (01) , 081-088
Abstract
MicroRNAs (miRNAs) are 20 to 24 nt long, single-stranded RNAs that repress gene expression. Dysregulation of miRNA expression is associated with many human diseases. Modulating the level of endogenous miRNA alters gene profiling and can achieve therapeutic benefits. Here the authors review currently used methods of altering miRNA activity in vivo. They focus on the delivery of miRNAs and miRNA inhibitors using recombinant adeno-associated virus (rAAV). In general, rAAV-mediated miRNA inhibition or overexpression provides a simple, efficient, and informative way to study miRNA function in mammals. This method also provides the opportunity to explore potential miRNA therapeutics for many diseases.Keywords
This publication has 71 references indexed in Scilit:
- Competing and noncompeting activities of miR-122 and the 5′ exonuclease Xrn1 in regulation of hepatitis C virus replicationProceedings of the National Academy of Sciences, 2012
- Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liverJournal of Clinical Investigation, 2012
- A Cardiac MicroRNA Governs Systemic Energy Homeostasis by Regulation of MED13Cell, 2012
- Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglyceridesNature, 2011
- Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosisJournal of Clinical Investigation, 2011
- MiR-33 Contributes to the Regulation of Cholesterol HomeostasisScience, 2010
- miR-375 maintains normal pancreatic α- and β-cell massProceedings of the National Academy of Sciences, 2009
- Suppression of non-small cell lung tumor development by the let-7 microRNA familyProceedings of the National Academy of Sciences, 2008
- RAS Is Regulated by the let-7 MicroRNA FamilyCell, 2005
- Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancersProceedings of the National Academy of Sciences, 2004